Business Description
Mouwasat Medical Services Co
ISIN : SA12C051UH11
Description
Mouwasat Medical Services Co is engaged in the acquisition, management, operation and maintenance of hospitals, medical centers, drug stores, pharmacies and wholesale of medical equipment and drugs. The company also operates skin care centers that offer clinical and cosmetic dermatology, aesthetic and reconstructive plastic surgery, weight reduction, and esthetician services. It operates in two segments Medical Services segment and Pharmaceuticals out of which the Medical Services segment derive majority of revenue.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.19 | |||||
| Equity-to-Asset | 0.66 | |||||
| Debt-to-Equity | 0.24 | |||||
| Debt-to-EBITDA | 0.79 | |||||
| Interest Coverage | 18.63 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 12.04 | |||||
| Beneish M-Score | -2.5 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 9.8 | |||||
| 3-Year EBITDA Growth Rate | 10.5 | |||||
| 3-Year EPS without NRI Growth Rate | 13.4 | |||||
| 3-Year FCF Growth Rate | 28.8 | |||||
| 3-Year Book Growth Rate | 12.9 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 16.2 | |||||
| Future 3-5Y Total Revenue Growth Rate | 15.64 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 37.08 | |||||
| 9-Day RSI | 45.77 | |||||
| 14-Day RSI | 50.86 | |||||
| 6-1 Month Momentum % | 31.65 | |||||
| 12-1 Month Momentum % | 8.74 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.95 | |||||
| Quick Ratio | 1.71 | |||||
| Cash Ratio | 0.18 | |||||
| Days Inventory | 53.76 | |||||
| Days Sales Outstanding | 157.42 | |||||
| Days Payable | 66.33 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.12 | |||||
| Dividend Payout Ratio | 0.46 | |||||
| 3-Year Dividend Growth Rate | 14.5 | |||||
| Forward Dividend Yield % | 1.12 | |||||
| 5-Year Yield-on-Cost % | 2.3 | |||||
| Shareholder Yield % | 1.48 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 48.53 | |||||
| Operating Margin % | 31.99 | |||||
| Net Margin % | 24.31 | |||||
| FCF Margin % | 19.49 | |||||
| ROE % | 21.46 | |||||
| ROA % | 13.67 | |||||
| ROIC % | 19.07 | |||||
| ROC (Joel Greenblatt) % | 20.51 | |||||
| ROCE % | 19.54 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 41.03 | |||||
| PE Ratio without NRI | 41.03 | |||||
| Shiller PE Ratio | 55.91 | |||||
| Price-to-Owner-Earnings | 59.81 | |||||
| PEG Ratio | 3.16 | |||||
| PS Ratio | 9.98 | |||||
| PB Ratio | 8.24 | |||||
| Price-to-Tangible-Book | 8.28 | |||||
| Price-to-Free-Cash-Flow | 51.18 | |||||
| Price-to-Operating-Cash-Flow | 33.15 | |||||
| EV-to-EBIT | 35.52 | |||||
| EV-to-EBITDA | 27.56 | |||||
| EV-to-Revenue | 10.16 | |||||
| EV-to-Forward-Revenue | 7.95 | |||||
| EV-to-FCF | 52.42 | |||||
| Price-to-Projected-FCF | 3.7 | |||||
| Price-to-DCF (Earnings Based) | 1.79 | |||||
| Price-to-DCF (FCF Based) | 1.63 | |||||
| Price-to-Median-PS-Value | 1.58 | |||||
| Price-to-Peter-Lynch-Fair-Value | 3.09 | |||||
| Price-to-Graham-Number | 3.88 | |||||
| Earnings Yield (Greenblatt) % | 2.82 | |||||
| FCF Yield % | 1.97 | |||||
| Forward Rate of Return (Yacktman) % | 14.63 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Mouwasat Medical Services Co Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ï·¼) | 2,705.509 | ||
| EPS (TTM) (ï·¼) | 3.29 | ||
| Beta | 0 | ||
| Volatility % | 27.03 | ||
| 14-Day RSI | 50.86 | ||
| 14-Day ATR (ï·¼) | 4.094814 | ||
| 20-Day SMA (ï·¼) | 136.9 | ||
| 12-1 Month Momentum % | 8.74 | ||
| 52-Week Range (ï·¼) | 92.5 - 144 | ||
| Shares Outstanding (Mil) | 200 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Mouwasat Medical Services Co Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Mouwasat Medical Services Co Stock Events
| Event | Date | Price(ï·¼) | ||
|---|---|---|---|---|
| No Event Data | ||||
Mouwasat Medical Services Co Frequently Asked Questions
What is Mouwasat Medical Services Co(SAU:4002)'s stock price today?
The current price of SAU:4002 is ï·¼134.20. The 52 week high of SAU:4002 is ï·¼144.00 and 52 week low is ï·¼92.50.
When is next earnings date of Mouwasat Medical Services Co(SAU:4002)?
The next earnings date of Mouwasat Medical Services Co(SAU:4002) is .
Does Mouwasat Medical Services Co(SAU:4002) pay dividends? If so, how much?
The Dividend Yield %  of Mouwasat Medical Services Co(SAU:4002) is 1.12% (As of Today), Highest Dividend Payout Ratio of Mouwasat Medical Services Co(SAU:4002) was 0.48. The lowest was 0.37. And the median was 0.42. The  Forward Dividend Yield % of Mouwasat Medical Services Co(SAU:4002) is 1.12%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers